BIOREM Inc.
BRM.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 79.25% | 55.49% | -60.02% | -11.34% | -11.89% |
| Total Depreciation and Amortization | -19.57% | -2.26% | -5.29% | 40.50% | 38.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.86% | 12.33% | -87.32% | -44.87% | -45.13% |
| Change in Net Operating Assets | -1,828.34% | 507.83% | 79.64% | 287.40% | 135.13% |
| Cash from Operations | -55.88% | 94.08% | -56.28% | -7.80% | 8.14% |
| Capital Expenditure | -466.86% | 4.50% | -34.64% | 31.94% | 88.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -466.86% | 4.50% | -34.64% | 31.94% | 88.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 6.43% | 6.38% | 4.32% | 50.32% | 51.34% |
| Issuance of Common Stock | -90.12% | -90.12% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -35.98% | -30.24% | 14.86% | 69.95% | 67.41% |
| Foreign Exchange rate Adjustments | -181.59% | -209.33% | -225.38% | 66.37% | 781.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -89.50% | 99.40% | -81.15% | 51.80% | 191.58% |